You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Truvada: The First Drug Approved to Prevent HIV Infection

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000422248.42341.b1
Drug Watch
Abstract

* Emtricitabine–tenofovir disoproxil fumarate (Truvada), a combination of two nucleoside analog HIV-1 reverse transcriptase inhibitors, is the first drug to be approved for the prevention of HIV infection in those who are at high risk for contracting HIV from a sexual partner.

* Truvada should be used as part of a comprehensive plan for prevention of disease transmission. It needs to be taken daily to achieve its therapeutic effect.

* It's important that a negative HIV status be confirmed before a patient begins therapy.

Author Information

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: daschen1@jhu.com.

© 2012 Lippincott Williams & Wilkins, Inc.